Huntsman Cancer Institute
Research facility
Location:
Salt Lake City, UT,
United States (USA) (US)
ISNI: 0000000404223447
ROR: https://ror.org/03v7tx966
Show on Map:
Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE) (2020)
Talhouk A, George J, Wang C, Budden T, Tan TZ, Chiu DS, Kommoss S, et al.
Journal article
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk (2020)
Liu J, Prager-van der Smissen WJ, Collée JM, Bolla MK, Wang Q, Michailidou K, Dennis J, et al.
Journal article
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020)
Escala-Garcia M, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Ashworth A, Auer PL, et al.
Journal article
Prognostic gene expression signature for high-grade serous ovarian cancer (2020)
Millstein J, Budden T, Goode EL, Anglesio MS, Talhouk A, Intermaggio MP, Leong HS, et al.
Journal article